NeuroPace, a medical technology company dedicated to transforming the lives of people suffering from epilepsy, has launched its nSight Platform, an online portal that helps physicians provide more personalized, data-driven epilepsy care by enabling them to remotely review patient progress, discover actionable insights, and track their clinic’s overall patient outcomes.
The RNS System is the only US FDA- approved epilepsy device that continuously monitors brain activity, delivers personalized treatment by responding in real time to a patient’s unique seizure activity, and records intracranial EEG data that can help physicians optimize patient outcomes.
“The RNS System provides drug- resistant epilepsy patients with unparalleled seizure reduction, while giving physicians unprecedented visibility into their patients’ ongoing brain activity,” said Mike Favet, CEO of NeuroPace. “We believe that the brain data captured by the RNS System is a major technology differentiator – it gives physicians additional information, so that they can make more informed treatment decisions for their patients. With the launch of the nSight Platform, the RNS System data is more streamlined, more accessible, and more actionable than ever before.”
As part of the nSight Platform offering, NeuroPace has partnered with Seizure Tracker https://seizuretracker.com/ one of the most widely used electronic seizure diary apps, to help patients and clinicians more reliably track and manage seizures. The Seizure Tracker mobile app gives patients and caregivers the ability to record videos of seizures as they happen, and log seizure events and details afterwards. It also integrates with Amazon Alexa so patients can verbally record when a seizure begins and ends.
Through the companies’ partnership, patients can elect to share Seizure Tracker information with their physicians through the nSight Platform. This enables physicians to better assess their patients’ seizure burden, identify potential seizure triggers, and see trends in seizure activity based on medication or lifestyle changes.
The nSight Platform is especially helpful with the growing demand for telehealth visits. For epilepsy patients, Seizure Tracker can provide a convenient way to track daily seizure activity and share this information with their doctor. For physicians, the nSight Platform can provide a more comprehensive picture of their patient’s epilepsy, all in one centralized place.
The RNS System
The RNS System, a paradigm-shifting treatment for drug-resistant focal epilepsy, is the only brain-responsive neuromodulation system approved by the FDA. The closed- loop technology delivers personalized, data- driven treatment targeted to the seizure source by continuously monitoring brain activity, recognizing a patient’s unique seizure pattern, and responding in real-time with imperceptible stimulation to prevent seizures. By recording ongoing EEG data, the RNS System provides physicians with a unique “window to the brain,” enabling them to remotely monitor their patients, gain insights based on brain activity, and use that information to optimize patient care.
Long-term clinical studies demonstrate that the RNS System provides significant reduction in seizure frequency and enduring improvements in quality of life and cognition, with no stimulation-related side effects.
- For more information, visit: www.neuropace.com
